What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
Thomas Thum focuses on Internal medicine, microRNA, Endocrinology, Heart failure and Disease.
His biological study spans a wide range of topics, including Downregulation and upregulation and Cardiology.
He interconnects Bioinformatics, RNA, Regulation of gene expression, Computational biology and Cardiac fibrosis in the investigation of issues within microRNA.
Within one scientific family, Thomas Thum focuses on topics pertaining to Endothelial stem cell under Endocrinology, and may sometimes address concerns connected to Progenitor cell, Nitric oxide, Endogeny and Senescence.
His Heart failure research is multidisciplinary, incorporating elements of Cancer research and Heart disease.
His work carried out in the field of Disease brings together such families of science as Genetics, Genome and Oncology.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts (1794 citations)
- MicroRNAs in the Human Heart A Clue to Fetal Gene Reprogramming in Heart Failure (792 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, microRNA, Heart failure, Cardiology and Endocrinology.
His work in the fields of Myocardial infarction, Biomarker, Ejection fraction and Muscle hypertrophy overlaps with other areas such as In patient.
His microRNA study combines topics from a wide range of disciplines, such as Cancer research, Bioinformatics, RNA, Disease and Cell biology.
His work deals with themes such as Heart disease and Pathology, which intersect with Heart failure.
Thomas Thum has researched Cardiology in several fields, including Circulating MicroRNA and Diastole.
As part of one scientific family, Thomas Thum deals mainly with the area of Endocrinology, narrowing it down to issues related to the Endothelial stem cell, and often Progenitor cell and Endothelium.
He most often published in these fields:
- Internal medicine (46.00%)
- microRNA (34.33%)
- Heart failure (28.00%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (46.00%)
- Heart failure (28.00%)
- Cardiology (24.50%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Heart failure, Cardiology, Disease and microRNA.
His Internal medicine study typically links adjacent topics like Endocrinology.
His Heart failure research is multidisciplinary, relying on both Cancer and Cardiotoxicity.
His Cardiology research incorporates elements of Diabetes mellitus and Diastole.
His microRNA research is multidisciplinary, incorporating perspectives in Blood plasma, Antisense oligonucleotides and Bioinformatics.
His Computational biology study combines topics from a wide range of disciplines, such as Autophagy and Oligonucleotide.
Between 2019 and 2021, his most popular works were:
- SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications. (56 citations)
- Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society (50 citations)
- European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failure. (44 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
His primary scientific interests are in Heart failure, Internal medicine, Cardiology, Disease and microRNA.
His work carried out in the field of Heart failure brings together such families of science as Cancer, Muscle hypertrophy, Myocardial infarction and Ischemia.
He integrates several fields in his works, including Internal medicine and In patient.
His study in Cardiology is interdisciplinary in nature, drawing from both Biomarker, Risk groups and Diastole.
His Disease research integrates issues from Sudden death, Computational biology, Omics and Cell biology.
His studies deal with areas such as Myocyte, Regulation of gene expression and Cancer research as well as microRNA.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
